AKAYCHA ROBINSON: Open Payments
NPI 1861149544 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,359 in 74 payments from 23 companies in 2025. Trend: 2023 $194 · 2024 $629 · 2025 $3,359
Food & beverage: $2,100Travel & lodging: $1,196Education: $64
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 13 | $1,690 |
| Actelion Pharmaceuticals US, Inc. | 10 | $352 |
| Novartis Pharmaceuticals Corporation | 11 | $206 |
| AstraZeneca Pharmaceuticals LP | 3 | $181 |
| ABIOMED | 4 | $165 |
| Novo Nordisk Inc | 4 | $110 |
| Merck Sharp & Dohme LLC | 6 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| BridgeBio Pharma, Inc. | 2 | $49 |
Products named: LEQVIO, OPSUMIT, WAINUA, Wegovy, CAPLYTA, UPTRAVI, JARDIANCE, VERQUVO.
Industry payments across SC — which companies pay providers there.
